We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

70 hedge funds and large institutions have $251M invested in Trinity Biotech in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

50% more call options, than puts

Call options by funds: $614K | Put options by funds: $409K

32% more capital invested

Capital invested by funds: $191M → $251M (+$60.4M)

9% more funds holding

Funds holding: 64 → 70 (+6)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
2.27%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
15
Increased
23
Reduced
24
Closed
8
Calls
$614K
Puts
$409K
Net Calls
+$205K
Net Calls Change
+$373K

Top Buyers

Rank Fund Capital Flow
1
CCMLC
Cardinal Capital Management LLC (Connecticut)
Connecticut
+$4.26M
2
TAM
THB Asset Management
Connecticut
+$3.4M
3
William Blair & Company
William Blair & Company
Illinois
+$2.82M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.01M
5
WA
Whitebox Advisors
Minnesota
+$1.95M

Top Sellers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
-$6.23M
2
Boston Partners
Boston Partners
Massachusetts
-$2.17M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.01M
4
UCFA
United Capital Financial Advisors
Texas
-$1.88M
5
CCM
Corsair Capital Management
New York
-$1.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
26
Putnam Investments
Massachusetts
$1.69M -$134K -1,371 -8%
WIC
27
Woodmont Investment Counsel
Tennessee
$1.67M -$196K -2,015 -12%
BCM
28
BBT Capital Management
Texas
$1.61M -$1.49M -15,240 -51%
NTCOC
29
Northern Trust Company of Connecticut
Connecticut
$1.57M +$1.41M +14,420 New
Morgan Stanley
30
Morgan Stanley
New York
$1.55M +$149K +1,526 +12%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.42M +$719K +7,380 +129%
BCA
32
Benchmark Capital Advisors
New York
$1.24M +$104K +1,071 +10%
GIP
33
Granite Investment Partners
California
$1.14M -$10.9K -112 -1%
CCM
34
Corsair Capital Management
New York
$1.13M -$1.64M -16,790 -62%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$1.09M -$205K -2,102 -17%
PCM
36
Perritt Capital Management
Illinois
$1.09M – – –
RJA
37
Raymond James & Associates
Florida
$883K +$255K +2,618 +48%
KPCM
38
Kings Point Capital Management
New York
$844K +$600K +6,155 +385%
US Bancorp
39
US Bancorp
Minnesota
$807K +$343K +3,519 +90%
Wells Fargo
40
Wells Fargo
California
$757K +$135K +1,389 +25%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$748K +$670K +6,877 New
Boston Partners
42
Boston Partners
Massachusetts
$743K -$2.17M -22,230 -77%
EIM
43
Essex Investment Management
Massachusetts
$691K -$50.7K -520 -8%
Group One Trading
44
Group One Trading
Illinois
$658K +$246K +2,519 +71%
SC
45
Skylands Capital
Wisconsin
$531K +$476K +4,880 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$482K -$734K -7,531 -63%
BG
47
Bahl & Gaynor
Ohio
$467K +$418K +4,293 New
PNC Financial Services Group
48
PNC Financial Services Group
Pennsylvania
$436K +$390K +4,000 New
SNC
49
Stifel Nicolaus & Co
Missouri
$395K – – –
Arrowstreet Capital
50
Arrowstreet Capital
Massachusetts
$349K +$312K +3,203 New
1
2
3 4

TRIB Hedge Fund Activity: Q3 2013 in Review

70 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2013, worth a combined $251M — up 32% from $191M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TRIB positions and 8 closed out — a net gain of 7 holders — while 23 added to existing stakes and 24 trimmed.

The largest buyer was Cardinal Capital Management LLC (Connecticut), adding an estimated $4.26M. The largest seller was Heartland Advisors, cutting an estimated $6.23M.

  • 70 institutional investors held Trinity Biotech (TRIB) as of Q3 2013, up from 64 in Q2 2013.
  • Funds reported $251M of Trinity Biotech stock for Q3 2013, up 32% quarter-over-quarter.
  • 15 funds opened new Trinity Biotech positions in Q3 2013 and 8 closed out, a net change of +7 holders.
  • The largest Trinity Biotech buyer in Q3 2013 was Cardinal Capital Management LLC (Connecticut), an estimated $4.26M added.
  • The largest Trinity Biotech seller in Q3 2013 was Heartland Advisors, an estimated $6.23M sold.

Based on aggregated 13F filings for Q3 2013.